Trivarx Ltd has released a press release.
September 2025 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- US-veteran mental health trial patient recruitment complete
- Acquisition of Stabl-Im technology and Private Placement
- Reinstatement to Official Quotation
- Extension of Trading Suspension
- Suspension from Quotation
Later from TrivarX
- TRI Exercises Option to Advance Acquisition of Stabl-Im
- Positive results from US-veteran mental health trial
- December 2025 Quarterly Activities Report and Appendix 4C
- Appendix 4D & Half-Year Financial Report to 31 December 2025
- Dr Danielle Meyrick appointed as CEO
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX